HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

N- (5- (4- bromophenyl)- 6- (2- (5- bromopyrimidin- 2- yloxy)ethoxy)pyrimidin- 4- yl)- N'- propylaminosulfonamide

structure in first source
Also Known As:
ACT 064992; ACT-064992; ACT064992; Actelion-1; macitentan
Networked: 33 relevant articles (7 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Iglarz, Marc: 4 articles (11/2015 - 12/2008)
2. Rubin, Lewis J: 3 articles (12/2015 - 08/2013)
3. Hess, Patrick: 3 articles (11/2015 - 12/2008)
4. Clozel, Martine: 3 articles (11/2015 - 12/2008)
5. He, Junqin: 3 articles (10/2015 - 02/2011)
6. Lehembre, François: 3 articles (10/2015 - 02/2011)
7. Fidler, Isaiah J: 3 articles (10/2015 - 02/2011)
8. Regenass, Urs: 3 articles (10/2015 - 02/2011)
9. Kim, Sun-Jin: 3 articles (10/2015 - 02/2011)
10. Sastry, B K S: 2 articles (12/2015 - 08/2013)

Related Diseases

1. Pulmonary Hypertension (Ayerza Syndrome)
2. Hypertrophy
3. Glioma (Gliomas)
4. Glioblastoma (Glioblastoma Multiforme)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. Endothelin Receptors (Endothelin Receptor)
2. bosentan (Tracleer)
3. Endothelins (Endothelin)
4. temozolomide (Temodar)
5. Paclitaxel (Taxol)
6. Endothelin B Receptor
7. Phenobarbital (Luminal)
8. Enzymes
9. Idiopathic pulmonary hypertension
10. Vascular Endothelial Growth Factor Receptors (VEGF Receptors)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)